Increased BMI alone does not reliably predict peri-operative complications or morbidity after metabolic surgery.
Guideline-Based Recommendations
Diagnosis
Use BMI along with assessment of obesity-related comorbidities to evaluate peri-operative risk.
Differentiate patients by metabolic health status rather than BMI alone for ASA-PS classification.
Management
Apply standardized metabolic surgery and anesthesia protocols consistent with ERAS guidelines.
Consider metabolic and cardiovascular comorbidities in peri-operative risk stratification beyond BMI.
Monitoring & Follow-up
Monitor peri-operative morbidity and mortality with attention to comorbidity profiles.
Use validated indices such as the Charlson Comorbidity Index for comprehensive risk assessment.
Risks
Recognize that BMI ≥ 40 kg/m2 alone may not increase peri-operative risk without severe systemic disease.
Obesity-related complications, not adipose tissue volume alone, contribute to anesthesia and surgical risks.
Patient & Prescribing Data
Patients undergoing primary or first-stage metabolic surgery with BMI ≥ 30 kg/m2
Patients with BMI ≥ 40 kg/m2 but no severe systemic disease may have lower complication rates than those with severe comorbidities despite similar ASA-PS III classification.
Clinical Best Practices
Assess both BMI and presence/severity of obesity-related comorbidities for accurate ASA-PS classification.
Avoid assigning higher ASA-PS scores solely based on BMI ≥ 40 kg/m2 without considering metabolic health.
Utilize comprehensive data registries like DATO for quality assurance and outcome monitoring in metabolic surgery.
Incorporate ERAS protocols to optimize peri-operative care in patients with obesity.
A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation